natgillin/translations-raw huggingface dataset:
Revlimid was also expected to be used for the maintenance treatment of newly diagnosed multiple myeloma patients who have not progressed following initial treatment with Revlimid, melphalan, and prednisone (other medicines to treat multiple myeloma), or following autologous stem cell transplant (a transplant of the patient's own blood-producing cells). 
Zdravilo Revlimid naj bi se uporabljalo tudi za vzdrževalno zdravljenje bolnikov z na novo diagnosticiranim multiplim mielomom, pri katerih po začetnem zdravljenju z zdravili Revlimid, melfalan in prednizon (drugimi zdravili za zdravljenje multiplega mieloma) ali po avtologni presaditvi matičnih celic (presaditev bolnikovih lastnih krvotvornih celic) ni prišlo do napredovanja bolezni.
Furthermore, since Revlimid was associated with an increased risk of developing new cancers, the CHMP could not rule out that the lack of a longer survival could be due to death caused by new cancers. 
Ker je bilo jemanje zdravila Revlimid povezano s povečanim tveganjem za pojav novih rakavih obolenj, CHMP ni mogel izključiti možnosti, da je lahko odsotnost daljšega preživetja posledica smrti zaradi pojava novih rakavih obolenj.
It is used in combination with dexamethasone (an antiinflammatory medicine) to treat adults with multiple myeloma whose disease has been treated at least once in the past (second-line treatment). 
Uporablja se v kombinaciji z deksametazonom (protivnetnim zdravilom) za zdravljenje odraslih z multiplim mielomom, ki so se v preteklosti zaradi te bolezni zdravili vsaj enkrat (zdravljenje druge izbire).
The second study compared Revlimid with placebo in patients who had received an autologous stem cell transplant. 
V drugi študiji so zdravilo Revlimid primerjali s placebom pri bolnikih, ki so prejeli avtologno presaditev matičnih celic.
Based on the review of the data and the company's response to the CHMP lists of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Revlimid could not have been approved to treat newly diagnosed multiple myeloma patients. 
Na podlagi pregleda podatkov in odgovorov družbe na sezname vprašanj, ki jih je zastavil CHMP, je odbor v času umika izrazil določene zadržke in je začasno menil, da zdravila Revlimid ni mogoče odobriti za zdravljenje bolnikov z na novo diagnosticiranim multiplim mielomom.
What is Revlimid? 
Kaj je zdravilo Revlimid?
Therefore, at the time of the withdrawal, the CHMP was of the opinion that the benefits of Revlimid in newly diagnosed multiple myeloma patients did not outweigh its risks. 
CHMP je zato v času umika menil, da koristi zdravila Revlimid pri bolnikih z na novo diagnosticiranim multiplim mielomom ne odtehtajo z njim povezanih tveganj.
The main measure of effectiveness was how long the patients survived without their disease getting worse. 
Glavno merilo učinkovitosti je bil čas, potreben do poslabšanja bolezni.
What is happening with Revlimid for the treatment of multiple myeloma? 
Kakšne so posledice za zdravilo Revlimid, indicirano za zdravljenje multiplega mieloma?
This study looked at how long patients survived after the transplant without their disease getting worse. 
V študiji so merili čas preživetja po presaditvi, potreben do poslabšanja bolezni.
The Committee was concerned that, while there was a clear benefit in terms of delaying the progression of the disease in newly diagnosed multiple myeloma patients, this did not lead to a meaningful improvement of symptoms and longer survival. 
Čeprav je bilo zdravilo učinkovito pri odložitvi napredovanja bolezni pri bolnikih z na novo diagnosticiranim multiplim mielomom, je bil odbor zaskrbljen zaradi dejstva, da to ni vodilo do pomembnega izboljšanja simptomov in daljšega časa preživetja.
What was Revlimid expected to be used for? 
Za kaj naj bi se zdravilo Revlimid uporabljalo?
How is Revlimid expected to work? 
Kako naj bi zdravilo Revlimid delovalo?
• 10 seconds has passed, 
• minilo je 10 sekund,
These must NEVER be re-used. 
NIKOLI jih ne smete ponovno uporabiti.
Read the instructions carefully and follow them step by step. 
Navodilo natančno preberite in ga upoštevajte korak za korakom.
However, some may be serious and require urgent medical treatment. 
Nekateri pa so lahko resni in zahtevajo takojšnje zdravljenje.
They will also tell you the prescribed amount (volume). 
Poleg tega vam bo povedal, kolikšna je predpisana količina (volumen).
Before you start 
Pred začetkom
• impotence. 
• impotenca.
Make sure you know the prescribed amount . 
Prepričajte se, da poznate predpisano količino.
• A 2nd “CLICK” is heard, 
• slišite drugi »KLIK«,
Fewer than half of at-risk subjects had an event. 
Manj kot polovica rizičnih preiskovancev je imela dogodek.
Particular attention regarding the risk for infection should be paid when treating the elderly. 
Posebna pozornost glede tveganja okužb je potrebna pri zdravljenju starejših oseb.
You will set the volume to the prescribed dose in a later step. 
Količino boste nastavili na predpisani odmerek v poznejšem koraku.
• DO NOT inject through clothes. 
• NE injicirajte skozi oblačila.
61352 Bad Homburg v. d. Höhe Germany 
61352 Bad Homburg v. d. Höhe Nemčija
• Orange Indicator has stopped and completely blocked the Viewing Window. 
• oranžni kazalnik se je ustavil in povsem zapolnil kontrolno okence.
ASDAS Inactive Disease hs-CRPd,f,g 
ASDAS neaktivna bolezen hs-CRPd, f, g
Most of the cases of tuberculosis occurred within the first eight months after initiation of therapy and may reflect recrudescence of latent disease. 
Večina primerov tuberkuloze se je pojavila v prvih osmih mesecih po začetku zdravljenja, mogoče je, da gre za ponoven izbruh latentne bolezni.
ASASa Partial Remission 
ASASa delna remisija
Maintenance Dose Starting at week 4 
Vzdrževalni odmerek z začetkom v 4. tednu
A few drops of liquid may come out of the needle, this is normal. 
Iz igle lahko izteče nekaj kapljic tekočine, kar je normalno.
Detailed instructions on how to inject Hulio are provided in Section 7 - Instructions for use. 
Podrobna navodila o tem, kako injicirati zdravilo Hulio, so navedena v poglavju 7 - Navodilo za uporabo.
• DO NOT touch the Orange Activator with your fingers (this is where the needle comes out). 
• NE dotikajte se oranžnega aktivatorja s svojimi prsti (tukaj izskoči igla).
This 1st “CLICK” signals the start of the injection. 
Prvi »KLIK« označuje začetek injiciranja.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 17 September 2018 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM Datum prve odobritve: 17. september 2018
Hidradenitis suppurativa (sometimes called ‘acne inversa') is a long-term and often painful inflammatory skin disease. 
Hidradenitis suppurativa (včasih imenovan tudi acne inversa) je dolgotrajna in pogosto boleča vnetna bolezen kože.
If you see air bubbles in the solution again, you may repeat this step up to 3 times. 
Če so v raztopini ponovno zračni mehurčki, lahko ta korak ponovite do trikrat.
In all situations described below, the benefit/risk balance of therapy should be very carefully considered. 
V vseh spodaj opisanih okoliščinah je treba zelo natančno pretehtati korist in tveganje zdravljenja.
≥30% Reduction in Skin Painb 
≥ 30 % zmanjšanje bolečine na kožib
• Stevens-Johnson syndrome; 
• Stevens-Johnsonov sindrom;
Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product. 
Bolniki z dedno intoleranco za fruktozo (HFI) ne smejo jemati/dobiti tega zdravila.
This leaflet was last revised in {MM/YYYY} 
Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}>.
Step 11 - Check and set prescribed dose 
11. korak - Preverite in pripravite predpisani odmerek.
Hulio may be available in other presentations depending on the individual treatment needs. 
Zdravilo Hulio je lahko na voljo v drugih oblikah, odvisno od individualnih potreb zdravljenja.
• slow healing of wounds. 
• počasno celjenje ran.
• In some patients the body may fail to produce enough of the blood cells that fight infections or help you to stop bleeding. 
• Pri nekaterih bolnikih telo ne ustvari dovolj krvnih celic, ki pomagajo pri premagovanju okužbe ali ustavitvi krvavitve.
• excessive night urination; 
• čezmerno uriniranje ponoči;
Week 24 BASDAIb 50 
24. teden BASDAIb 50
Table 19: Maintenance regimen 
Preglednica 19: Vzdrževalni režim
Monoclonal antibodies are proteins that attach to specific target in the body. 
Monoklonska protitelesa so beljakovine, ki se vežejo na specifične tarče v telesu.
Table 25: Maintenance regimen 
Preglednica 25: Vzdrževalni režim
In rare cases, these infections may be lifethreatening. 
V redkih primerih so lahko te okužbe življenjsko ogrožujoče.
• pain in bone and muscles. 
• bolečine v kosteh in mišicah.
• Wait for the skin to dry on its own, do not blow it dry. 
• Počakajte, da se koža sama posuši in je ne sušite.
Scarring may also occur in affected areas. 
Na prizadetih območjih se lahko pojavijo tudi brazgotine.
Hulio can also be given alone. 
Zdravilo Hulio se lahko daje tudi samo.
Each pack is for single use only 
Vsako pakiranje je namenjeno samo za enkratno uporabo.
An asterisk (*) appears in the System Organ Class (SOC) column if further information is found elsewhere in sections 4.3, 4.4 and 4.8. 
V koloni Organski sistem (OS) se pojavi zvezdica (*), če je nadaljnje informacije mogoče najti drugod v poglavjih 4.3, 4.4 in 4.8.
If there is a second box in the Hulio pack for a future injection, place it back in the refrigerator immediately. 
Če pakiranje zdravila Hulio vsebuje še eno škatlo za naslednje injiciranje, jo nemudoma shranite nazaj v hladilnik.
You and your doctor should pay special attention to signs of infection while you are being treated with Hulio. 
Vi sami in vaš zdravnik morata biti posebej pozorna na znake okužbe, medtem ko ste zdravljeni z zdravilom Hulio.
• If you are over 65 years you may be more susceptible to infections while taking Hulio. 
• Če ste starejši od 65 let, ste morda dovzetnejši za okužbe, če jemljete zdravilo Hulio.
Limited information from the published literature indicates that adalimumab is excreted in breast milk at very low concentrations with the presence of adalimumab in human milk at concentrations of 0.1% to 1% of the maternal serum level. 
Omejeni podatki iz objavljene literature kažejo, da se adalimumab izloča v materino mleko v zelo nizkih koncentracijah, s prisotnostjo adalimumaba v človeškem mleku v koncentraciji 0.1 % do 1 % glede na materin serum.
• According to a pregnancy study, there was no higher risk of birth defects when the mother had received Hulio during pregnancy compared with mothers with the same disease who did not receive Hulio. 
Glede na študijo pri nosečnicah ni bilo povečanega tveganja za okvare pri rojstvu, če je mati prejemala zdravilo Hulio med nosečnostjo v primerjavi z materami z isto boleznijo, ki niso prejemale zdravila Hulio.
• difficulty sleeping; 
• težave s spanjem;
Percent Change in Total Fingernail NAPSI (%) 
Odstotek spremembe v celotnem indeksu NAPSI (%) za nohte
Hulio in combination with methotrexate, is indicated for: 
Zdravilo Hulio je v kombinaciji z metotreksatom indicirano za:
a HR of adalimumab vs placebo from proportional hazards regression with treatment as factor. 
a RT adalimumaba v primerjavi s placebom iz regresije proporcionalnih tveganj z zdravljenjem kot faktorjem.
• Throw away all other used items and empty packaging into your regular household waste. 
• Zavrzite vse ostale uporabljene enote in prazno ovojnino zdravila v običajen koš za odpadke.
If you don't know this, STOP HERE and ask your child's doctor. 
Če tega ne veste, se TUKAJ USTAVITE in vprašajte otrokovega zdravnika.
Prior to launch of Hulio in each Member State the Marketing Authorisation Holder (MAH) must agree about the content and format of the educational programme, including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority. 
Pred začetkom trženja zdravila Hulio se mora imetnik dovoljenja za promet z zdravilom s pristojnim nacionalnim organom v vsaki državi članici dogovoriti o vsebini in obliki izobraževalnega programa, vključno s komunikacijskimi mediji, načinom razdeljevanja in drugimi vidiki programa.
Multipack containing 2 (2 packs of 1) vials. 
Večkratno pakiranje vsebuje 2 (2 pakiranji po 1) viali.
Worsening or new onset of psoriasis (including palmoplantar pustular psoriasis)1), 
pogosti poslabšanje ali nov pojav psoriaze (vključno s palmoplantarno pustularno psoriazo)1),
The educational program consists of a Patient Reminder Card. 
Izobraževalni program vsebuje opozorilno kartico za bolnike.
If needed, cover the injection site with a plaster. 
Po potrebi injekcijsko mesto prekrijte z obližem.
Hulio is supplied as packs containing 1 or 2 boxes. 
Zdravilo Hulio je na voljo v pakiranju, ki vsebuje 1 ali 2 škatli.
hydrochloric acid and water for injections. 
klorovodikova kislina in voda za injekcije.
A large number (approximately 2,100) of prospectively collected pregnancies exposed to adalimumab resulting in live birth with known outcomes, including more than 1,500 exposed during the first trimester, does not indicate an increase in the rate of malformation in the newborn. 
Veliko število (približno 2100) v naprej izbranih nosečnosti, med katerimi so bile matere izpostavljene adalimumabu in jim je sledilo rojstvo živorojenih otrok z znanim izidom, vključno s 1500 izpostavljenimi v prvem trimesečju, ne nakazuje povečanja razmerja malformacij pri novorojenčkih.
Wash your hands thoroughly with soap and water. 
Dobro si umijte roki z milom in vodo.
Patients in clinical response (decrease in CDAI ≥ 70) at week 4 were stratified and analysed separately from those not in clinical response at week 4. 
Bolnike s kliničnim odzivom (znižanje CDAI ≥ 70) v 4. tednu so stratificirali in analizirali ločeno od bolnikov brez kliničnega odziva v 4. tednu.
Patients who achieved PASI 75 and PGA clear or minimal were withdrawn from treatment for up to 36 weeks and monitored for loss of disease control (i.e. a worsening of PGA by at least 2 grades). 
Bolniki, ki so dosegli PASI 75 in PGA čisto ali minimalno, so bili iz zdravljenja odpuščeni do 36 tednov in spremljani glede izgube nadzora nad boleznijo (tj. poslabšanje PGA za najmanj 2 stopnji).
Reports included cases of pulmonary and extra-pulmonary (i.e. disseminated) tuberculosis. 
Poročila so vključevala primere pljučne in zunajpljučne (tj. Diseminirane) tuberkuloze.
Hulio is intended for the treatment of the following inflammatory diseases: 
Zdravilo Hulio je namenjeno za zdravljenje naslednjih vnetnih bolezni:
In case there is a need for a more rapid response to therapy with the awareness that the risk for adverse events may be higher with use of the higher induction dose, the following dose may be used: 
V primeru, ko je potreben hitrejši odziv na zdravljenje, z zavedanjem, da je tveganje za pojav neželenih učinkov lahko povečano ob uporabi večjega začetnega odmerka, se lahko uporabi naslednji odmerek:
Erosion score 3.7 (2.7-4.7) 1.7 (1.0-2.4) 
Ocena erozij 3,7 (2,7-4,7) 1,7 (1,0-2,4)
If retreatment with Hulio is indicated, the above guidance on dose and treatment duration should be followed. 
Če je indicirano vnovično zdravljenje z zdravilom Hulio, je treba upoštevati zgoraj navedena navodila za odmerjanje in trajanje zdravljenja.
Continue holding the body of the pen down against the injection site until one, or all, of the following occur: 
Injekcijski peresnik še naprej držite navzdol proti injekcijskemu mestu, dokler se ne zgodi eno ali vse od naštetega:
By attaching to TNFα, Hulio decreases the process of inflammation in these diseases. 
Z vezavo na TNFα zdravilo Hulio zmanjša vnetni proces pri teh boleznih.
Repeat this step to draw the solution back into the syringe again, pulling the plunger rod SLOWLY. 
Ponovite ta korak, da raztopino ponovno povlečete v brizgo, in sicer tako, da nosilec bata POČASI potegnete ven.
Contents of the pack and other information Instructions for use 
Vsebina pakiranja in dodatne informacije Navodilo za uporabo
It is also normal to see air bubble(s). 
Normalno je tudi, da so vidni zračni mehurčki.
Patient reported outcomes regarding vision-related functioning were measured in both clinical studies, using the NEI VFQ-25. 
Izidi poročil bolnikov glede opravil, povezanih z vidom, so bili merjeni v obeh kliničnih študijah z uporabo vprašalnika NEI VFQ25.
TNF-antagonists, such as adalimumab affect the immune system and their use may affect the body's defence against infection and cancer. 
TNF-antagonisti, kot je adalimumab, prizadenejo imunski sistem, njihova uporaba lahko vpliva na obrambo telesa proti okužbi in raku.
Components inside the pen may be broken. 
Sestavni deli v injekcijskem peresniku so morda zlomljeni.
Treatment with Hulio can be initiated in combination with corticosteroids and/or with other non-biologic immunomodulatory agents. 
Zdravljenje z zdravilom Hulio se lahko začne v kombinaciji s kortikosteroidi in/ali z drugimi nebiološkimi imunomodulatorji.
Disease flare criteria were defined as a worsening of ≥ 30% from baseline in ≥ 3 of 6 Pediatric ACR core criteria, ≥ 2 active joints, and improvement of > 30% in no more than 1 of the 6 criteria. 
Merila zagona bolezni so bila opredeljena kot poslabšanje ≥ 3 od 6 osnovnih meril Pediatric ACR za ≥ 30 % v primerjavi z izhodiščem, ≥ 2 aktivna sklepa in izboljšanje na več kot 1 od 6 meril za > 30 %.
• DO NOT re-cap or touch the needle with your fingers, or let the needle touch anything. 
• NE nameščajte pokrovčka nazaj na iglo in se ne dotikajte igle s svojimi prsti ter ne dovolite, da se igla česar koli dotakne.
Time to Treatment Failure At or After week 6 in Study UV I Primary analysis (ITT) Placebo Adalimumab Time to Treatment Failure At or After week 2 in Study UV II Primary analysis (ITT) Placebo Adalimumab 
Čas do neuspeha zdravljenja v ali po 6. tednu v študiji UV I Primarna analiza (ITT) placebo adalimumab Čas do neuspeha zdravljenja v ali po 2. tednu v študiji UV II Primarna analiza (ITT) placebo adalimumab
• Certain vaccines contain living but weakened forms of bacteria or viruses that cause diseases and should not be given during treatment with Hulio in case they cause infections. 
• Določena cepiva vsebujejo žive, a oslabljene oblike bakterij ali virusov, ki povzročajo bolezni, in se jih med zdravljenjem z zdravilom Hulio ne sme uporabljati, ker lahko povzročijo okužbe.
Concurrent administration of biologic DMARDS or TNF-antagonists 
Sočasna uporaba bioloških antirevmatikov DMARD ali antagonistov TNF
After adjustment for weight differences, gender and age appeared to have a minimal effect on adalimumab clearance. 
Po korekciji za razlike v masi se je izkazalo, da spol in starost po vsem sodeč minimalno vplivata na očistek adalimumaba.
Your child's doctor, nurse or other healthcare professional will show you how to prepare the injection and give it to your child. 
Otrokov zdravnik, medicinska sestra ali drug zdravstveni delavec vam bo pokazal, kako pripraviti injekcijo in jo dati vašemu otroku.
ASAS Partial Remission BASDAIb 50 
delna remisija ASAS BASDAIb 50
When you are sure the adapter is attached to the vial, lift off the packaging. 
Ko ste prepričani, da je adapter nameščen na vialo, snemite ovojnino.
• 1 vial adapter (2) 
• 1 adapter za vialo (2);
If your child has moderate or severe heart failure. 
- če ima vaš otrok zmerno ali hudo srčno popuščanje.
Medication Orange Indicator 
Oranžni kazalnik
The European Medicines Agency has deferred the obligation to submit the results of the studies with the reference medicinal product containing adalimumab in one or more subsets of the paediatric population in ulcerative colitis, see section 4.2 for information on paediatric use. 
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij za referenčno zdravilo, ki vsebuje adalimumab, za eno ali več podskupin pediatrične populacije z ulceroznim kolitisom (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
Travel/recurrent infection 
Okužbe na potovanju/ponavljajoče se okužbe
This medicinal product contains sorbitol (E420). 
To zdravilo vsebuje sorbitol (E420).
• mild allergic reactions (including seasonal allergy); 
• blage alergijske reakcije (vključno s sezonskimi alergijami);
• signs of skin cancer such as a bump or open sore that doesn't heal; 
• znake kožnega raka, kot so bula ali odprta rana, ki se ne zaceli;
Concomitant corticosteroids may be tapered in accordance with clinical practice starting two weeks after initiating treatment with Hulio. 
Kortikosteroide, ki se jih daje sočasno, se lahko postopoma ukinja v skladu s klinično prakso, z začetkom dva tedna po začetku zdravljenja z zdravilom Hulio.
Tuberculosis can develop during therapy even if your child have had preventative treatment for tuberculosis. 
Tuberkuloza se lahko razvije med zdravljenjem, tudi če je vaš otrok prejel preventivno zdravljenje za tuberkulozo.
The primary endpoint was ‘time to treatment failure'. 
Primarni opazovani dogodek je bil ''čas do neuspeha zdravljenja''.
• If the plunger is not pressed all the way the safety feature will not activate afterwards to cover the needle. 
• Če bata ne potisnete do konca, se po injiciranju ne bo aktiviral varnostni sistem, ki pokrije iglo.
Hypersensitivity, allergies (including seasonal allergy) 
pogosti preobčutljivost, alergije (vključno s sezonsko alergijo)
Induction of clinical remission (defined as CDAI < 150) was evaluated in two studies, CD Study I (CLASSIC I) and CD Study II (GAIN). 
Indukcijo klinične remisije (opredeljene kot CDAI < 150) so ocenili v dveh študijah, študiji Crohnove bolezni I (CLASSIC I) in študiji Crohnove bolezni II (GAIN).
Tuberculosis can develop during therapy even if you have had preventative treatment for tuberculosis. 
Tuberkuloza se lahko razvije med zdravljenjem, tudi če ste prejeli preventivno zdravljenje za tuberkulozo.
After proper training, the injection can be self-administered or given by another person, for example a family member or carer. 
Po ustreznem urjenju si lahko injekcije dajete sami ali vam jih daje kdo drug, npr. svojec ali skrbnik.
PGA-F clear/minimal and ≥2-grade improvement (%) 
PGA-F čisto/minimalno in izboljšanje za ≥ 2 razreda
• dry eyes, dry mouth; 
• suhe oči, suha usta;
Efficacy Outcomes Double Blind 32 weeks Adalimumab /MTX (N = 38) 
Rezultati učinkovitosti Dvojno slepa 32 tednov Adalimumab/MTX (N = 38)
• new or worsening psoriasis (red, flaky skin); 
• pojav ali poslabšanje psoriaze (rdeča, luskava koža);
Adalimumab n=274 confidence interval) 
adalimumab n = 274 interval zaupanja)
c Ankylosing Spondylitis Disease Activity Score d Partial flare is defined as ASDAS ≥ 1.3 but < 2.1 at 2 consecutive visits. 
Score) d delni zagon bolezni je določen kot ASDAS ≥ 1,3, vendar < 2,1 pri 2 zaporednih obiskih.
During the withdrawal period, symptoms of psoriasis returned over time with a median time to relapse (decline to PGA “moderate” or worse) of approximately 5 months. 
Med obdobjem prenehanja uporabe so se simptomi psoriaze sčasoma znova pojavili; mediani čas do ponovitve simptomov psoriaze (relapsa) (poslabšanje na PGA »zmerno« ali slabše) je bil približno 5 mesecev.
To help you remember which day(s) of the week Hulio should be injected, it may be helpful to make a note on a calendar or in a diary. 
Da si boste lažje zapomnili, na kateri dan (dneve) v tednu morate injicirati zdravilo Hulio, je priporočljivo, da si to zapišete v koledar ali dnevnik.
Before initiation of therapy with Hulio, all patients must be evaluated for both active or inactive (“latent”) tuberculosis infection. 
Pred začetkom zdravljenja z zdravilom Hulio je treba vse bolnike pregledati glede aktivne ali neaktivne (latentne) tuberkulozne okužbe.
What Hulio is and what it is used for 
Kaj je zdravilo Hulio in za kaj ga uporabljamo
• If the white plunger rod is pulled out of the syringe, discard the syringe and contact your Hulio provider for a replacement. 
• Če beli nosilec bata potegnete iz brizge, brizgo zavrzite in se z dobaviteljem zdravila Hulio dogovorite za njeno nadomestitev.
• nerve damage; 
• poškodba živcev;